PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2758
https://www.valueinhealthjournal.com/article/S1098-3015(18)36060-1/fulltext
Title :
PSY184 - HTA AND REIMBURSEMENT CONSIDERATIONS FOR RARE DISEASES IN EUROPEAN MARKETS- WHAT ARE THE IMPLICATIONS FOR MANUFACTURERS?S?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)36060-1&doi=10.1016/j.jval.2018.09.2758
First page :
Section Title :
Open access? :
No
Section Order :
2114